Remimazolam NeuroImaging
RecruitingEarly phase 1Healthy volunteers welcome
Neuroimaging of Sedation With Remimazolam
Who can join
Ages 18 to 59 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Adults 18-59 years of age, who: * have none of the specific exclusion criteria * have a valid email address and valid phone number throughout the study * free from any non-MRI compatible implants Exclusion Criteria: * are pregnant or attempting to conceive * body mass index (BMI) \> 35 * significant memory impairment or hearing loss * sleep apnea * chronic pain or frequently taking pain medication (including tramadol) * chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol) * neurologic disease, including seizures and tremor * psychiatric diagnoses, including anxiety, depression, panic, or PTSD * a history of any of these medical conditions: abnormal heartbeats (cardiac conduction abnormality or arrhythmia), liver or kidney disease, or significant lung disease * severe claustrophobia or MRI intolerance * have metal implants or non-removable metal piercings * having a history of adverse reaction to midazolam (Versed), lorazepam (Ativan) or another benzodiazepine class medication * are allergic to dextran * daily alcohol or heavy alcohol use; history of alcohol abuse * current daily smoker * regular or recent marijuana use (including prescribed/medical marijuana) * illicit drug use, i.e., street drugs * regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines, anti-anxiety medication, stimulants, or sleep-aids
About the study
This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task
What is being tested
- Remimazolam (drug)
- Peripheral Nerve Stimulation (device)
Sponsor: Keith M Vogt · Participants: 60 · Started: Mar 27, 2026
Contact the study team
- Keith M Vogt, MD, PhD · Phone: 4126473147
Official record on ClinicalTrials.gov — NCT07290205
Locations in the U.S.
| Pennsylvania | University of Pittsburgh, Pittsburgh |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.